Scientists have uncovered a new target for the potential treatment of TB, finally resolving a long-running ... -resistant strains (XDR-TB) means the search for new treatments is imperative. Unlike human ...
Scientists have uncovered a new target for the potential treatment of TB, finally resolving a long-running debate about how the bacterial cell wall is built. The research, published in Microbiology ...
... and latent tuberculosis and will lead to a new and more effective treatment for TB.
“Once inside the human macrophage, ... Organization (WHO). Ten million new cases of TB arise every year, killing close ...
... -line drugs, isoniazid and rifampin. XDR-TB is resistant to rifampin, isoniazid, a fluoroquinolone and a second ... 1984 and 1998 of 75 percent for treatment of MDR-TB. Subsequent analysis revealed initial ...
... will give hope that significantly better prevention and treatment of TB will be available within the next few years. The Aeras Global TB Vaccine Foundation, which was founded to develop new, cost- ...
... injection drug users whose latent TB infection becomes active is destined to increase, ... researchers.
"This at-risk population urgently needs better screening and treatment for TB,"said Laniado-Laborin ...
... regimen. Six subjects (3 in each treatment group), discontinued the study prematurely. This first ... validate ATP synthase as a viable target for the treatment of TB.
"The nearly half a million estimated ...
... address the long-term persistent bacteria in the lung and other parts of the body.
"If we could shorten the treatment for TB, that would be very powerful in breaking the transmission cycle," said ...
... setting after adjusting for inflation.
"Our analysis showed that the costs associated with screening and preventive treatment for TB among HIV-infected patients was comparable to the cost related to ...
... the effect of various regimens on almost 2,000 patients (some receiving their first treatment for TB, others being retreated) with resistance to isoniazid alone. This meta-analysis found lower relapse ...
... 7 percent in 1993 to 32 percent in 2005. XDR TB occurred due to inadequate ... Prevention is more cost-effective than treatment, they noted.
"Globally, XDR TB has resulted from a combination of poor ...
... take longer to clear the TB bacterium during the first phase of treatment than TB patients who are not diabetic. ... 8.9 million new cases of TB worldwide," the researchers wrote. "Our data showed that ...
... compounds are able to kill actively growing TB bacteria but are unable to kill resting, dormant ... current first-line treatment of TB and are the sole current treatments that can relatively rapidly reduce ...
... is not ready for use in humans, researchers have said it is a step toward a single drug that targets multiple pathways, which could save time and money over the current multi-drug treatment for TB.
... the reactivation of latent TB. None of the patients who received correct prophylactic treatment for TB which is in France in most of the cases the association of INH and rifampicione for 3 months. ...
